Formation focus

SV has tweaked the strategy for its sixth fund, focusing more of its biotech investment where it has made the best returns: in seed and series A investments. The firm also has diversified its LP base, adding strategics for the first time.

SV Health Investors (formerly SV Life Sciences) closed SV VI on April 11 at its target of $400 million. ...